The Ewing’s Sarcoma EWS/FLI-1 Fusion Gene Encodes a More Potent Transcriptional Activator and is a More Powerful Transforming Gene than FLI-1

References

• Ben-David, Y., E. B. Giddens, K. Letwin, and A. Bernstein. 1991. Erythroleukemia induction by Friend murine leukemia virus: insertional activation of a new member of the ets gene family Fli-1, closely linked to c-ets-l. Genes Dev. 5:908–918.
   PubMed Web of Science ®Google Scholar
• Borrow, J., A. D. Goddard, D. Sheer, and E. Solomon. 1990. Molecular analysis of acute promyelocytic leukemia breakpoint cluster region on chromosome 17. Science 249:1577–1580.
   PubMed Web of Science ®Google Scholar
• Chumakov, A. M., D. L. Chen, E. A. Chumakova, and H. P. Koeffler. 1993. Localization of the c-ets-2 transactivation domain. J. Virol. 67:2421–2425.
   PubMedGoogle Scholar
• Crozat, A., P. Amant, N. Mandahl, and D. Ron. 1993. Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma. Nature (London) 363:640–644.
   PubMed Web of Science ®Google Scholar
• Dalton, S., and R. Treisman. 1992. Characterization of SAP-1, a protein recruited by serum response factor to the c-fos serum response element. Cell 68:597–612.
   PubMed Web of Science ®Google Scholar
• Delattre, O., J. Zucman, B. Plougastel, C. Desmaze, T. Melot, M. Peter, H. Kovar, I. Joubert, P. de Jong, G. Rouleau, A. Aurias, and G. Thomas. 1992. Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours. Nature (London) 358:62–165.
   Google Scholar
• de The, H., C. Chomienne, M. Lanotte, L. Degos, and A. Dejean. 1990. The t(15;17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor alpha gene to a novel transcribed locus. Nature (London) 347:558–561.
   PubMed Web of Science ®Google Scholar
• Hoey, T., R. O. Weinzierl, G. Gill, J. L. Chen, B. D. Dynlacht, and R. Tjian. 1993. Molecular cloning and functional analysis of Drosophila TAF110 reveal properties expected of coactivators. Cell 72:247–260.
   PubMedGoogle Scholar
• Kamps, M. P., C. Murre, X. H. Sun, and D. Baltimore. 1990. A new homeobox gene contributes the DNA binding domain of the t(l;19) translocation protein in pre-B ALL. Cell 60:547–555.
   PubMed Web of Science ®Google Scholar
• Klemsz, M. J., R. A. Maki, T. Papayannopoulou, J. Moore, and R. Hromas. 1993. Characterization of the ets oncogene family member, fli-1. J. Biol. Chem. 268:5769–5773.
   PubMedGoogle Scholar
• Lewin, B.%% 1991. Oncogenic conversion by regulatory changes in transcription factors. Cell 64:303–312.
   PubMed Web of Science ®Google Scholar
• Lim, F., N. Kraut, J. Frampton, and T. Graf. 1992. DNA binding by c-Ets-1, but not v-Ets-1, is repressed by an intramolecular mechanism. EMBO J. 11:643–652.
   PubMed Web of Science ®Google Scholar
• Lin, Y. S., and M. R. Green. 1991. Mechanism of action of an acidic transcriptional activator in vitro. Cell 64:971–981.
   PubMed Web of Science ®Google Scholar
• May, W. A., M. L. Gishizsky, S. L. Lessnick, L. B. Lunsford, B. C. Lewis, O. Delattre, J. Zucman, G. Thomas, and C. T. Denny. 1993. Ewing sarcoma 11;22 translocation produces a chimeric transcription factor that requires the DNA-binding domain encoded by FLI1 for transformation. Proc. Natl. Acad. Sci. USA 90:5752–5756.
   PubMed Web of Science ®Google Scholar
• Metz, T., and T. Graf. 1991. Fusion of the nuclear oncoproteins v-Myb and v-Ets is required for the leukemogenicity of E26 virus. Cell 66:95–105.
   PubMed Web of Science ®Google Scholar
• Metz, T., and T. Graf. 1991. v-myb and v-ets transform chicken erythroid cells and cooperate both in trans and in cis to induce distinct differentiation phenotypes. Genes Dev. 5:369–380.
   PubMedGoogle Scholar
• Mitchell, P., and R. Tjian. 1989. Transcriptional regulation in mammalian cell by sequence-specific DNA binding proteins. Science 245:371–378.
   PubMed Web of Science ®Google Scholar
• Moreau-Gachelin, F., A. Tavitian, and P. Tambourin. 1988. Spi-1 is a putative oncogene in virally induced murine erythro-leukemias. Nature (London) 331:277–280.
   PubMed Web of Science ®Google Scholar
• Muller, A. J., J. C. Young, A.-M. Pendergast, M. Pondel, N. R. Landau, D. R. Littman, and O. N. Witte. 1991. BCR first exon sequences specifically activate the BCR/ABL tyrosine kinase oncogene of Philadelphia chromosome-positive human leuke-mias. Mol. Cell. Biol. 11:1785–1792.
   PubMed Web of Science ®Google Scholar
• Nourse, J., J. D. Mellentin, N. Galili, J. Wilkinson, E. Stan-bridge, S. D. Smith, and M. L. Cleary. 1990. Chromosomal translocation t(l;19) results in synthesis of a homeobox fusion mRNA that codes for a potential chimeric transcription factor. Cell 60:535–545.
   PubMed Web of Science ®Google Scholar
• Roberts, S. G. E., 1. Ha, E. Maldonado, D. Reinberg, and M. R. Green. 1993. Interaction between an acidic activator and transcription factor TFIIB is required for transcriptional activation. Nature (London) 363:741–744.
   PubMedGoogle Scholar
• Seneca, S., B. Punyammalee, M. Bailly, J. Ghysdael, and M. Crabeel. 1991. Etsl, when fused to the GAL4 DNA binding domain, efficiently enhances galactose promoter dependent gene expression in yeast. Oncogene 6:357–360.
   PubMedGoogle Scholar
• Seth, A., D. K. Watson, D. G. Blair, and T. S. Papas. 1989. c-ets-2 protooncogene has mitogenic activity. Proc. Natl. Acad. Sci. USA 86:7833–7837.
   PubMed Web of Science ®Google Scholar
• Stringer, K. F., C. J. Ingles, and J. Greenblatt. 1990. Direct and selective binding of an acidic transcriptional activation domain to the TATA-box factor TFIID. Nature (London) 345:783–786.
   PubMedGoogle Scholar
• Thompson, C. C., T. A. Brown, and S. L. McKnight. 1991. Convergence of Ets- and notch-related structural motifs in a heteromeric DNA binding complex. Science 253:762–768.
   PubMed Web of Science ®Google Scholar
• Topol, L. Z., A. G. Tatosyan, R. Ascione, D. M. Thompson, D. G. Blair, I. Kola, and A. Seth. 1992. c-ets-l protooncogene expression alters the growth properties of immortalized rat fibroblastsy. Cancer Lett. 67:71–78.
   PubMedGoogle Scholar
• Wasylyk, B., S. L. Hahn, and A. Giovane. 1993. The Ets family of transcription factors. Eur. J. Biochem. 211:7–18.
   PubMedGoogle Scholar
• Wasylyk, C., J.-P. Kerckaert, and B. Wasylyk. 1992. A novel modulator of Ets transcription factors. Gene Dev. 6:965–974.
   PubMed Web of Science ®Google Scholar
• Watanabe, S. M., N. E. Rosenberg, and O. N. Witte. 1984. A membrane-associated, carbohydrate-modified form of the w-abl protein that cannot be phosphorylated in vivo or in vitro. J. Virol. 51:620–627.
   PubMedGoogle Scholar
• Watson, D. K., F. E. Smyth, D. M. Thompson, J. Q. Cheng, J. R. Testa, T. S. Papas, and A. Seth. 1992. The ERGB/Fli-1 gene: isolation and characterization of a new member of the family of ETS transcription factors. Cell Growth Differ. 3:705–713.
   PubMedGoogle Scholar
• Whang-Peng, J., T. J. Triche, T. Knutsen, J. Miser, S. Kao-Shan, S. Tsai, and M. A. Israel. 1986. Cytogenetic characterization of selected small round cell tumors of childhood. Cancer Genet. Cytogenet. 21:185–208.
   PubMed Web of Science ®Google Scholar
• Wu, Y. L., S. P. Tam, and P. L. Davies. 1990. A modified CAT expression vector with convenient cloning sites. Nucleic Acids Res. 18:1919.
   PubMedGoogle Scholar
• Zhang, L., V. Lemarchandel, P.-H. Romeo, Y. Ben-David, P. Greer, and A. Bernstein. 1993. The FLI-1 proto-oncogene, involved in erythroleukemia and Ewing’s sarcoma, encodes a transcriptional activator with DNA-binding specificities distinct from other Ets family members. Oncogene 8:1621–1630.
   PubMedGoogle Scholar